Gluskin Sheff & Assoc Inc Amgen Inc Transaction History

Gluskin Sheff & Assoc Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $477,908 - $546,922	-2,403 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $510,084 - $597,626	2,403 New	2,403 $511,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $561,292 - $622,713	-2,403 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $533,249 - $621,415	2,403 New	2,403 $598,000
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $11 Million - $12.4 Million	-60,933 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $10.9 Million - $12.7 Million	60,933 New	60,933 $11.9 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.